Obstructive Sleep Apnea, Pain, and Opioid Analgesia in the Postoperative Patient

Current Anesthesiology Reports

Volumn 4, Issue 1, 2014, Pages 1-9

  Doufas, Anthony G ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OUTCOMES RESEARCH CONSORTIUM   (United States)

Author keywords

Anesthesia; Obstructive sleep apnea (OSA); Opioid induced ventilatory impairment (OIVI); Opioids; Postoperative pain; Respiratory depression

Indexed keywords

EID: 84952718286     PISSN: 21676275     EISSN: 15233855     Source Type: Journal    
DOI: 10.1007/s40140-013-0047-0     Document Type: Article

References (122)

1. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006–14. DOI: 10.1093/aje/kws342
2. Finkel KJ, Searleman AC, Tymkew H, et al. Prevalence of undiagnosed obstructive sleep apnea among adult surgical patients in an academic medical center. Sleep Med. 2009;10(7):753–8. DOI: 10.1016/j.sleep.2008.08.007
3. Singh M, Liao P, Kobah S, Wijeysundera DN, Shapiro C, Chung F. Proportion of surgical patients with undiagnosed obstructive sleep apnoea. Br J Anaesth. 2013;110(4):629–36. DOI: 10.1093/bja/aes465
4. Young T, Evans L, Finn L, Palta M. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep. 1997;20(9):705–6.
5. Memtsoudis SG, Besculides MC, Mazumdar M. A rude awakening—the perioperative sleep apnea epidemic. N Engl J Med. 2013;368(25):2352–3. DOI: 10.1056/NEJMp1302941
6. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378–84. DOI: 10.1056/NEJM200005113421901
7. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353(19):2034–41. DOI: 10.1056/NEJMoa043104
8. Punjabi NM, Beamer BA. Alterations in glucose disposal in sleep-disordered breathing. Am J Respir Crit Care Med. 2009;179(3):235–40. DOI: 10.1164/rccm.200809-1392OC
9. Brown KA, Morin I, Hickey C, Manoukian JJ, Nixon GM, Brouillette RT. Urgent adenotonsillectomy: an analysis of risk factors associated with postoperative respiratory morbidity. Anesthesiology. 2003;99(3):586–95. DOI: 10.1097/00000542-200309000-00013
10. Gali B, Whalen FX, Schroeder DR, Gay PC, Plevak DJ. Identification of patients at risk for postoperative respiratory complications using a preoperative obstructive sleep apnea screening tool and postanesthesia care assessment. Anesthesiology. 2009;110(4):869–77. DOI: 10.1097/ALN.0b013e31819b5d70
11. • Ramachandran SK, Haider N, Saran KA, et al: Life-threatening critical respiratory events: a retrospective study of postoperative patients found unresponsive during analgesic therapy. J Clin Anesth 2011;23(3):207–13. Between 2000 and 2007, 32 among 87,650 patients experienced a postoperative life-threatening critical respiratory event (LT-CRE), while 26 events and three deaths occurred within the first 24 hours of opioid therapy. Four out of 32 patients died. Congestive heart failure, postoperative acute renal failure, obstructive sleep apnea, diabetes mellitus, and hypertension were significantly associated with LT-CREs in adult patients.
12. Gupta RM, Parvizi J, Hanssen AD, Gay PC. Postoperative complications in patients with obstructive sleep apnea syndrome undergoing hip or knee replacement: a case–control study. Mayo Clin Proc. 2001;76(9):897–905.
13. Chung SA, Yuan H, Chung F. A systemic review of obstructive sleep apnea and its implications for anesthesiologists. Anesth Analg. 2008;107(5):1543–63. DOI: 10.1213/ane.0b013e318187c83a
14. •• Mokhlesi B, Hovda MD, Vekhter B, Arora VM, Chung F, Meltzer DO. Sleep-disordered breathing and postoperative outcomes after elective surgery: analysis of the Nationwide Inpatient Sample. Chest. 2013;144(3):903–14. In a nationwide retrospective cohort (1,058,710 inpatients between 2004 and 2008) regression analysis estimated significantly higher odds ratio for emergent intubation and mechanical ventilation, noninvasive ventilation, and atrial fibrilation in sleep-disordered breathing (SDB) than in non-SDB patients, after four different types of general surgical procedures. Interestingly, emergent intubations occurred much earlier in the postoperative period in patients with SDB.
15. •• Memtsoudis S, Liu SS, Ma Y, et al. Perioperative pulmonary outcomes in patients with sleep apnea after noncardiac surgery. Anesth Analg. 2011;112(1):113–21. The authors retrospectively examined a natiowide cohort of 2,610,441 patients who underwent orthopedic and 3,441,262 patients who underwent general surgical procedures performed between 1998 and 2007. A preoperative diagnosis of sleep apnea (SA) is an independent risk factor for perioperative pulmonary complications like emergent intubation and mechanical ventilation.
16. Ankichetty S, Wong J, Chung F. A systematic review of the effects of sedatives and anesthetics in patients with obstructive sleep apnea. J Anaesthesiol Clin Pharmacol. 2011;27(4):447–58. DOI: 10.4103/0970-9185.86574
17. •• Macintyre PE, Loadsman JA, Scott DA. Opioids, ventilation and acute pain management. Anaesth Intensive Care. 2011;39(4):545–58. A detailed introduction of the concept of opioid-induced ventilatory impairment (OIVI) in the setting of acute postoperative pain management. The authors discuss factors that could enhance sensitivity to the central and/or peripheral respiratory depressants effects of opioids, including obstructive sleep apnea and obesity hypoventilation syndromes.
18. Kundermann B, Spernal J, Huber MT, Krieg JC, Lautenbacher S. Sleep deprivation affects thermal pain thresholds but not somatosensory thresholds in healthy volunteers. Psychosom Med. 2004;66(6):932–7. DOI: 10.1097/01.psy.0000145912.24553.c0
19. Onen SH, Alloui A, Gross A, Eschallier A, Dubray C. The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects. J Sleep Res. 2001;10(1):35–42. DOI: 10.1046/j.1365-2869.2001.00240.x
20. Haack M, Lee E, Cohen DA, Mullington JM. Activation of the prostaglandin system in response to sleep loss in healthy humans: potential mediator of increased spontaneous pain. Pain. 2009;145(1–2):136–41. DOI: 10.1016/j.pain.2009.05.029
21. Haack M, Sanchez E, Mullington JM. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep. 2007;30(9):1145–52.
22. •• Smith MT, Edwards RR, McCann UD, Haythornthwaite JA. The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep. 2007;30(4):494–505. Partial sleep deprivation using the forced-awakening paradigm impaired the function of pain-inhibitory processes and increased spontaneous pain in healthy women.
23. Roehrs T, Hyde M, Blaisdell B, Greenwald M, Roth T. Sleep loss and REM sleep loss are hyperalgesic. Sleep. 2006;29(2):145–51.
24. Moldofsky H, Scarisbrick P. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med. 1976;38(1):35–44.
25. Lentz MJ, Landis CA, Rothermel J, Shaver JL. Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women. J Rheumatol. 1999;26(7):1586–92.
26. • Edwards RR, Almeida DM, Klick B, Haythornthwaite JA, Smith MT. Duration of sleep contributes to next-day pain report in the general population. Pain. 2008;137(1):202–7. In a representative national sample of 971 adults, the authors used structural equation modeling to show that hours of reported sleep on the previous night were highly predictive of the current day’s pain frequency. Obtaining less than 6 or more than 9 hours sleep per night was associated with greater pain in the next day.
27. Chhangani BS, Roehrs TA, Harris EJ, et al. Pain sensitivity in sleepy pain-free normals. Sleep. 2009;32(8):1011–7.
28. Roehrs TA, Harris E, Randall S, Roth T. Pain sensitivity and recovery from mild chronic sleep loss. Sleep. 2012;35(12):1667–72.
29. Haack M, Scott-Sutherland J, Santangelo G, Simpson NS, Sethna N, Mullington JM. Pain sensitivity and modulation in primary insomnia. Eur J Pain. 2012;16:522–33. DOI: 10.1016/j.ejpain.2011.07.007
30. Smith MT, Wickwire EM, Grace EG, et al. Sleep disorders and their association with laboratory pain sensitivity in temporomandibular joint disorder. Sleep. 2009;32(6):779–90.
31. Smith MT, Klick B, Kozachik S, et al. Sleep onset insomnia symptoms during hospitalization for major burn injury predict chronic pain. Pain. 2008;138(3):497–506. DOI: 10.1016/j.pain.2008.01.028
32. Raymond I, Nielsen TA, Lavigne G, Manzini C, Choiniere M. Quality of sleep and its daily relationship to pain intensity in hospitalized adult burn patients. Pain. 2001;92(3):381–8. DOI: 10.1016/S0304-3959(01)00282-2
33. Haack M, Pollmacher T, Mullington JM. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers. Brain Behav Immun. 2004;18(4):361–7. DOI: 10.1016/j.bbi.2003.12.009
34. • Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med. 2006;166(16):1756–62. Partial sleep deprivation (awake from 11 PM to 3 AM) in 30 healthy volunteers was associated with an increase in the expression of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) by peripheral blood monocytes.
35. Edwards RR, Grace E, Peterson S, Klick B, Haythornthwaite JA, Smith MT. Sleep continuity and architecture: associations with pain-inhibitory processes in patients with temporomandibular joint disorder. Eur J Pain. 2009;13(10):1043–7. DOI: 10.1016/j.ejpain.2008.12.007
36. Edwards RR, Quartana PJ, Allen RP, Greenbaum S, Earley CJ, Smith MT. Alterations in pain responses in treated and untreated patients with restless legs syndrome: associations with sleep disruption. Sleep Med. 2011;12(6):603–9. DOI: 10.1016/j.sleep.2010.09.018
37. 2) from 92 to 75 % approximately doubled the odds for experiencing pain.
38. Smith MT, Finan PH. Sleep, respiration, and pain: a potential nexus for chronic pain risk? Anesthesiology. 2013;119(5):1011–3. DOI: 10.1097/ALN.0b013e3182a9521b
39. Brown KA, Laferriere A, Moss IR. Recurrent hypoxemia in young children with obstructive sleep apnea is associated with reduced opioid requirement for analgesia. Anesthesiology. 2004;100(4):806–10. DOI: 10.1097/00000542-200404000-00009
40. 2≥ 85 %) in children was associated with a 50 % reduction in the morphine requirement for the management of post-adenotonsillectomy pain.
41. Laferriere A, Liu JK, Moss IR. Neurokinin-1 versus mu-opioid receptor binding in rat nucleus tractus solitarius after single and recurrent intermittent hypoxia. Brain Res Bull. 2003;59(4):307–13. DOI: 10.1016/S0361-9230(02)00915-2
42. Moss IR, Laferriere A. Central neuropeptide systems and respiratory control during development. Respir Physiol Neurobiol. 2002;131(1–2):15–27. DOI: 10.1016/S1569-9048(02)00034-4
43. Brown KA. Intermittent hypoxia and the practice of anesthesia. Anesthesiology. 2009;110(4):922–7. DOI: 10.1097/ALN.0b013e31819c480a
44. Moss IR, Brown KA, Laferriere A. Recurrent hypoxia in rats during development increases subsequent respiratory sensitivity to fentanyl. Anesthesiology. 2006;105(4):715–8. DOI: 10.1097/00000542-200610000-00017
45. Kajimura S, Aida K, Duan C. Insulin-like growth factor-binding protein-1 (IGFBP-1) mediates hypoxia-induced embryonic growth and developmental retardation. Proc Natl Acad Sci USA. 2005;102(4):1240–5. DOI: 10.1073/pnas.0407443102
46. •• Doufas AG, Tian L, Padrez KA, et al. Experimental pain and opioid analgesia in volunteers at high risk for obstructive sleep apnea. PLoS One. 2013;8(1):e54807. In adults suffering from obstructive sleep apnea, nocturnal hypoxemia (measured by the nadir arterial saturation during polysomnography) is associated with increased analgesic sensitivity to remifentanil, a short-acting opioid. Insulin growth factor binding protein-1 (IGFBP-1), a serum marker of hypoxia, is also associated with increased analgesic potency of remifentanil.
47. Sanders JC, King MA, Mitchell RB, Kelly JP. Perioperative complications of adenotonsillectomy in children with obstructive sleep apnea syndrome. Anesth Analg. 2006;103(5):1115–21. DOI: 10.1213/01.ane.0000244318.77377.67
48. Sadhasivam S, Chidambaran V, Ngamprasertwong P, et al. Race and unequal burden of perioperative pain and opioid related adverse effects in children. Pediatrics. 2012;129(5):832–8. DOI: 10.1542/peds.2011-2607
49. Xie A, Bedekar A, Skatrud JB, Teodorescu M, Gong Y, Dempsey JA. The heterogeneity of obstructive sleep apnea (predominant obstructive vs pure obstructive apnea). Sleep. 2011;34(6):745–50.
50. •• Younes M. Role of respiratory control mechanisms in the pathogenesis of obstructive sleep disorders. J Appl Physiol. 2008;105(5):1389–405. Based on evidence from experimental and clinical studies, the author discusses the role of respiratory control mechanisms in the pathogenesis of obstructive sleep apnea. Apart from the anatomical narrowing of the airway, parameters like the effective recruitment threshold of pharyngeal dilators, the arousal threshold, and the rate of rise of the chemical drive during an obstructive event, determine post-obstruction ventilatory overshoot and are major determinants of the polysomnographic features of the disease.
51. Dempsey JA, Veasey SC, Morgan BJ, O’Donnell CP. Pathophysiology of sleep apnea. Physiol Rev. 2010;90(1):47–112. DOI: 10.1152/physrev.00043.2008
52. • White DP, Younes MK. Obstructive sleep apnea. Compr Physiol. 2012;2(4):2541–94. An excellent, very detailed review of the most recent evidence and theories regarding the pathophysiology of obstructive sleep apnea.
53. Younes M. Contributions of upper airway mechanics and control mechanisms to severity of obstructive apnea. Am J Respir Crit Care Med. 2003;168(6):645–58. DOI: 10.1164/rccm.200302-201OC
54. Koo CY, Eikermann M. Respiratory effects of opioids in perioperative medicine. Open Anesthesiol J. 2011;5(Suppl 1-M6):23–34.
55. •• Isono S, Remmers JE, Tanaka A, Sho Y, Sato J, Nishino T. Anatomy of pharynx in patients with obstructive sleep apnea and in normal subjects. J Appl Physiol (1985). 1997;82(4):1319–26. The first study to conclusively demonstrate the presence of anatomical abnormalities such as increased narrowing and collapsibility of the passive pharynx in humans suffering from obstructive sleep apnea.
56. Horner RL. Motor control of the pharyngeal musculature and implications for the pathogenesis of obstructive sleep apnea. Sleep. 1996;19(10):827–53.
57. Horner RL, Hughes SW, Malhotra A. State-dependent and reflex drives to the upper airway: basic physiology with clinical implication. J Appl Physiol (1985). 2013;. doi:10.1152/japplphysiol.00531.2013.
58. Loewen AH, Ostrowski M, Laprairie J, Maturino F, Hanly PJ, Younes M. Response of genioglossus muscle to increasing chemical drive in sleeping obstructive apnea patients. Sleep. 2011;34(8):1061–73.
59. Younes M, Loewen AH, Ostrowski M, Laprairie J, Maturino F, Hanly PJ. Genioglossus activity available via non-arousal mechanisms vs. that required for opening the airway in obstructive apnea patients. J Appl Physiol (1985). 2012;112(2):249–58. DOI: 10.1152/japplphysiol.00312.2011
60. Younes M, Ostrowski M, Atkar R, Laprairie J, Siemens A, Hanly P. Mechanisms of breathing instability in patients with obstructive sleep apnea. J Appl Physiol. 2007;103(6):1929–41. DOI: 10.1152/japplphysiol.00561.2007
61. Pialoux V, Hanly PJ, Foster GE, et al. Effects of exposure to intermittent hypoxia on oxidative stress and acute hypoxic ventilatory response in humans. Am J Respir Crit Care Med. 2009;180(10):1002–9. DOI: 10.1164/rccm.200905-0671OC
62. Babcock M, Shkoukani M, Aboubakr SE, Badr MS. Determinants of long-term facilitation in humans during NREM sleep. J Appl Physiol (1985). 2003;94(1):53–9.
63. Harris DP, Balasubramaniam A, Badr MS, Mateika JH. Long-term facilitation of ventilation and genioglossus muscle activity is evident in the presence of elevated levels of carbon dioxide in awake humans. Am J Physiol Regul Integr Comp Physiol. 2006;291(4):R1111–9. DOI: 10.1152/ajpregu.00896.2005
64. Younes M. Role of arousals in the pathogenesis of obstructive sleep apnea. Am J Respir Crit Care Med. 2004;169(5):623–33. DOI: 10.1164/rccm.200307-1023OC
65. Wang D, Marshall NS, Duffin J, et al. Phenotyping interindividual variability in obstructive sleep apnoea response to temazepam using ventilatory chemoreflexes during wakefulness. J Sleep Res. 2011;20(4):526–32. DOI: 10.1111/j.1365-2869.2011.00931.x
66. Smith I, Lasserson TJ, Wright J. Drug therapy for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. 2006;(2):CD003002.
67. Mokhlesi B, Tulaimat A, Parthasarathy S. Oxygen for obesity hypoventilation syndrome: a double-edged sword? Chest. 2011;139(5):975–7. DOI: 10.1378/chest.10-2858
68. Eckert DJ, Owens RL, Kehlmann GB, et al. Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold. Clin Sci (Lond). 2011;120(12):505–14. DOI: 10.1042/CS20100588
69. Eikermann M, Fassbender P, Zaremba S, et al. Pentobarbital dose-dependently increases respiratory genioglossus muscle activity while impairing diaphragmatic function in anesthetized rats. Anesthesiology. 2009;110(6):1327–34. DOI: 10.1097/ALN.0b013e3181a16337
70. Hudgel DW, Hendricks C, Dadley A. Alteration in obstructive apnea pattern induced by changes in oxygen- and carbon-dioxide-inspired concentrations. Am Rev Respir Dis. 1988;138(1):16–9. DOI: 10.1164/ajrccm/138.1.16
71. Eckert DJ, Younes MK. Arousal from sleep: implications for obstructive sleep apnea pathogenesis and treatment. J Appl Physiol (1985). 2013; doi:10.1152/japplphysiol.00649.2013.
72. Stuth EA, Stucke AG, Zuperku EJ. Effects of anesthetics, sedatives, and opioids on ventilatory control. Compr Physiol. 2012;2(4):2281–367.
73. •• Dahan A, Romberg R, Teppema L, Sarton E, Bijl H, Olofsen E. Simultaneous measurement and integrated analysis of analgesia and respiration after an intravenous morphine infusion. Anesthesiology. 2004;101(5):1201–9. First study to demonstrate in humans that systems involved in the analgesic and respiratory-depressant effects of opioids share important pharmacodynamic characteristics like similar onset/offset times and similar sensitivities to morphine.
74. Weil JV, McCullough RE, Kline JS, Sodal IE. Diminished ventilatory response to hypoxia and hypercapnia after morphine in normal man. N Engl J Med. 1975;292(21):1103–6. DOI: 10.1056/NEJM197505222922106
75. Berkenbosch A, Teppema LJ, Olievier CN, Dahan A. Influences of morphine on the ventilatory response to isocapnic hypoxia. Anesthesiology. 1997;86(6):1342–9. DOI: 10.1097/00000542-199706000-00016
76. Pattinson KT, Governo RJ, MacIntosh BJ, et al. Opioids depress cortical centers responsible for the volitional control of respiration. J Neurosci. 2009;29(25):8177–86. DOI: 10.1523/JNEUROSCI.1375-09.2009
77. McKay LC, Feldman JL. Unilateral ablation of pre-Botzinger complex disrupts breathing during sleep but not wakefulness. Am J Respir Crit Care Med. 2008;178(1):89–95. DOI: 10.1164/rccm.200712-1901OC
78. McKay LC, Janczewski WA, Feldman JL. Sleep-disordered breathing after targeted ablation of preBotzinger complex neurons. Nat Neurosci. 2005;8(9):1142–4. DOI: 10.1038/nn1517
79. •• Montandon G, Qin W, Liu H, Ren J, Greer JJ, Horner RL. PreBotzinger complex neurokinin-1 receptor-expressing neurons mediate opioid-induced respiratory depression. J Neurosci. 2011;31(4):1292–301. This experimental work establishes in adult rats that neurokinin-1 receptor-expressing neurons in the preBötzinger complex of medulla are responsible for mediating the respiratory depressant effect (i.e., decrease in respiratory rate) of opioids.
80. Dahan A, Aarts L, Smith TW. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology. 2010;112(1):226–38. DOI: 10.1097/ALN.0b013e3181c38c25
81. Hillman DR, Platt PR, Eastwood PR. The upper airway during anaesthesia. Br J Anaesth. 2003;91(1):31–9. DOI: 10.1093/bja/aeg126
82. Borgbjerg FM, Nielsen K, Franks J. Experimental pain stimulates respiration and attenuates morphine-induced respiratory depression: a controlled study in human volunteers. Pain. 1996;64(1):123–8. DOI: 10.1016/0304-3959(95)00088-7
83. Sarton E, Dahan A, Teppema L, et al. Acute pain and central nervous system arousal do not restore impaired hypoxic ventilatory response during sevoflurane sedation. Anesthesiology. 1996;85(2):295–303. DOI: 10.1097/00000542-199608000-00011
84. Karan S, Voter W, Palmer L, Ward DS. Effects of pain and audiovisual stimulation on the opioid-induced depression of the hypoxic ventilatory response. Anesthesiology. 2005;103(2):384–90. DOI: 10.1097/00000542-200508000-00022
85. •• Cashman JN, Dolin SJ. Respiratory and haemodynamic effects of acute postoperative pain management: evidence from published data. Br J Anaesth. 2004;93(2):212–23. The authors reviewed a total of 165 published investigations (nearly 20,000 patients) providing evidence for opioid-related adverse effects in the context of postoperative pain management. Across different analgesic techniques, the incidence of opioid-induced respiratory depression defined by low respiratory rate was less than 1 %.
86. 2< 90 %: 0.9 %), hypoventilation (respiratory rate < 8 breaths/min: 0.2 %), and airway obstruction (stridor or laryngospasm: 0.2 %) was estimated at 1.3 %.
87. Overdyk FJ, Hillman DR. Opioid modeling of central respiratory drive must take upper airway obstruction into account. Anesthesiology. 2011;114(1):219–20. DOI: 10.1097/ALN.0b013e3181fef383
88. Niesters M, Overdyk F, Smith T, Aarts L, Dahan A. Opioid-induced respiratory depression in paediatrics: a review of case reports. Br J Anaesth. 2013;110(2):175–82. DOI: 10.1093/bja/aes447
89. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002;165(5):670–6. DOI: 10.1164/ajrccm.165.5.2103001
90. Liu A, Kushida CA, Reaven GM. Risk for obstructive sleep apnea in obese, nondiabetic adults varies with insulin resistance status. Sleep Breath. 2013;17(1):333–8. DOI: 10.1007/s11325-012-0696-0
91. Mancini M, Filippelli M, Seghieri G, et al. Respiratory muscle function and hypoxic ventilatory control in patients with type I diabetes. Chest. 1999;115(6):1553–62. DOI: 10.1378/chest.115.6.1553
92. Resnick HE, Redline S, Shahar E, et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care. 2003;26(3):702–9. DOI: 10.2337/diacare.26.3.702
93. Weisbrod CJ, Eastwood PR, O’Driscoll G, Green DJ. Abnormal ventilatory responses to hypoxia in Type 2 diabetes. Diabet Med. 2005;22(5):563–8. DOI: 10.1111/j.1464-5491.2005.01458.x
94. • Cronin AJ, Keifer JC, Davies MF, King TS, Bixler EO. Postoperative sleep disturbance: influences of opioids and pain in humans. Sleep. 2001;24(1):39–44. Postoperative sleep disturbance, characterized by a great reduction in slow wave and rapid eye movement sleep, were affected by neither adequate pain control nor elimination of the use of opioids.
95. Krenk L, Jennum P, Kehlet H. Sleep disturbances after fast-track hip and knee arthroplasty. Br J Anaesth. 2012;109(5):769–75. DOI: 10.1093/bja/aes252
96. Rosenberg-Adamsen S, Kehlet H, Dodds C, Rosenberg J. Postoperative sleep disturbances: mechanisms and clinical implications. Br J Anaesth. 1996;76(4):552–9. DOI: 10.1093/bja/76.4.552
97. •• Lydic R, Baghdoyan HA. Sleep, anesthesiology, and the neurobiology of arousal state control. Anesthesiology. 2005;103(6):1268–95. A detailed review about the cellular and molecular mechanisms contributing to arousal state control with special reference to the action of anesthetics and opioids.
98. Lydic R, Keifer JC, Baghdoyan HA, Becker L. Microdialysis of the pontine reticular formation reveals inhibition of acetylcholine release by morphine. Anesthesiology. 1993;79(5):1003–12. DOI: 10.1097/00000542-199311000-00019
99. Mortazavi S, Thompson J, Baghdoyan HA, Lydic R. Fentanyl and morphine, but not remifentanil, inhibit acetylcholine release in pontine regions modulating arousal. Anesthesiology. 1999;90(4):1070–7. DOI: 10.1097/00000542-199904000-00021
100. Nelson AM, Battersby AS, Baghdoyan HA, Lydic R. Opioid-induced decreases in rat brain adenosine levels are reversed by inhibiting adenosine deaminase. Anesthesiology. 2009;111(6):1327–33. DOI: 10.1097/ALN.0b013e3181bdf894
101. Wu M, Sahbaie P, Zheng M, et al. Opiate-induced changes in brain adenosine levels and narcotic drug responses. Neuroscience. 2013;228:235–42. DOI: 10.1016/j.neuroscience.2012.10.031
102. Li Y, van den Pol AN. Mu-opioid receptor-mediated depression of the hypothalamic hypocretin/orexin arousal system. J Neurosci. 2008;28(11):2814–9. DOI: 10.1523/JNEUROSCI.5447-07.2008
103. Cronin A, Keifer JC, Baghdoyan HA, Lydic R. Opioid inhibition of rapid eye movement sleep by a specific mu receptor agonist. Br J Anaesth. 1995;74(2):188–92. DOI: 10.1093/bja/74.2.188
104. Moore JT, Kelz MB. Opiates, sleep, and pain: the adenosinergic link. Anesthesiology. 2009;111(6):1175–6. DOI: 10.1097/ALN.0b013e3181bdfa2e
105. • Bernards CM, Knowlton SL, Schmidt DF, et al. Respiratory and sleep effects of remifentanil in volunteers with moderate obstructive sleep apnea. Anesthesiology. 2009;110(1):41–49. Administration of remifentanil in subjects suffering from moderate obstructive sleep apnea (OSA) decreased obstructive and increased central apneas, likely due to the marked reduction in rapid eye movement sleep. As a consequence, remifentanil administration also decreased arterial oxy-hemoglobin saturation.
106. Knill RL, Moote CA, Skinner MI, Rose EA. Anesthesia with abdominal surgery leads to intense REM sleep during the first postoperative week. Anesthesiology. 1990;73(1):52–61. DOI: 10.1097/00000542-199007000-00009
107. Rosenberg J, Wildschiodtz G, Pedersen MH, von Jessen F, Kehlet H. Late postoperative nocturnal episodic hypoxaemia and associated sleep pattern. Br J Anaesth. 1994;72(2):145–50. DOI: 10.1093/bja/72.2.145
108. Chau EH, Lam D, Wong J, Mokhlesi B, Chung F. Obesity hypoventilation syndrome: a review of epidemiology, pathophysiology, and perioperative considerations. Anesthesiology. 2012;117(1):188–205. DOI: 10.1097/ALN.0b013e31825add60
109. Bowdle TA. Nocturnal arterial oxygen desaturation and episodic airway obstruction after ambulatory surgery. Anesth Analg. 2004;99(1):70–6. DOI: 10.1213/01.ANE.0000125113.03812.2A
110. Catley DM, Thornton C, Jordan C, Lehane JR, Royston D, Jones JG. Pronounced, episodic oxygen desaturation in the postoperative period: its association with ventilatory pattern and analgesic regimen. Anesthesiology. 1985;63(1):20–8. DOI: 10.1097/00000542-198507000-00004
111. Overdyk FJ, Carter R, Maddox RR, Callura J, Herrin AE, Henriquez C. Continuous oximetry/capnometry monitoring reveals frequent desaturation and bradypnea during patient-controlled analgesia. Anesth Analg. 2007;105(2):412–8. DOI: 10.1213/01.ane.0000269489.26048.63
112. Shahinyan A, Sun Z, Finnegan PS, et al. Duration and incidence of postoperative hypoxemia. In: Presented at the annual meeting of the American Society of Anesthesiologists. 2013;119:BOC12.
113. •• Liao P, Luo Q, Elsaid H, Kang W, Shapiro CM, Chung F. Perioperative auto-titrated continuous positive airway pressure treatment in surgical patients with obstructive sleep apnea: a randomized controlled trial. Anesthesiology. 2013;119(4):837–47. The postoperative application of continuous positive airway pressure (CPAP) decreased the frequency of apnea/hyponea events and improved nocturnal oxygenation in surgical patients with obstructive sleep apnea. However, patients’ adherence to CPAP was less than 50 %.
114. Kaw R, Michota F, Jaffer A, Ghamande S, Auckley D, Golish J. Unrecognized sleep apnea in the surgical patient: implications for the perioperative setting. Chest. 2006;129(1):198–205. DOI: 10.1378/chest.129.1.198
115. Oertel BG, Felden L, Tran PV, et al. Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia. Clin Pharmacol Ther. 2010;87(2):204–11. DOI: 10.1038/clpt.2009.194
116. Dahan A, Roozekrans M, van der Schrier R, Smith T, Aarts L. Primum non nocere or how to resolve drug-induced respiratory depression. Anesthesiology. 2013;118(6):1261–3. DOI: 10.1097/ALN.0b013e31829107d5
117. Teppema LJ, Bijl H, Romberg RR, Dahan A. Antioxidants reverse depression of the hypoxic ventilatory response by acetazolamide in man. J Physiol. 2006;572(Pt 3):849–56. DOI: 10.1113/jphysiol.2005.104174
118. Teppema LJ, Romberg RR, Dahan A. Antioxidants reverse reduction of the human hypoxic ventilatory response by subanesthetic isoflurane. Anesthesiology. 2005;102(4):747–53. DOI: 10.1097/00000542-200504000-00009
119. Meuret P, Backman SB, Bonhomme V, Plourde G, Fiset P. Physostigmine reverses propofol-induced unconsciousness and attenuation of the auditory steady state response and bispectral index in human volunteers. Anesthesiology. 2000;93(3):708–17. DOI: 10.1097/00000542-200009000-00020
120. Hedner J, Kraiczi H, Peker Y, Murphy P. Reduction of sleep-disordered breathing after physostigmine. Am J Respir Crit Care Med. 2003;168(10):1246–51. DOI: 10.1164/rccm.200211-1344OC
121. Eikermann M, Grosse-Sundrup M, Zaremba S, et al. Ketamine activates breathing and abolishes the coupling between loss of consciousness and upper airway dilator muscle dysfunction. Anesthesiology. 2012;116(1):35–46. DOI: 10.1097/ALN.0b013e31823d010a
122. Niesters M, Mahajan RP, Aarts L, Dahan A. High-inspired oxygen concentration further impairs opioid-induced respiratory depression. Br J Anaesth. 2013;110(5):837–41. DOI: 10.1093/bja/aes494